Up to now, the number of IPOs listed on the Beijing Stock Exchange during the year is close to 60, the highest since 2024. What is more noteworthy is that the number of companies currently queued for IPO on the Beijing Stock Exchange has reached 223, which is more than the Shanghai and Shenzhen markets combined. With the narrowing of the Shanghai and Shenzhen listing channels, the Beijing Stock Exchange has accepted more demand for IPOs, but it is not easy for companies to go public on the Beijing Stock Exchange now. A number of industry insiders pointed out to reporters that on the surface, the number of audits and listings on the Beijing Stock Exchange has clearly accelerated, but due to a greater focus on the properties of novel and innovative drugs, it is actually becoming more difficult for companies to go public.

Up to now, the number of IPOs listed on the Beijing Stock Exchange during the year is close to 60, the highest since 2024. What is more noteworthy is that the number of companies currently queued for IPO on the Beijing Stock Exchange has reached 223, which is more than the Shanghai and Shenzhen markets combined. With the narrowing of the Shanghai and Shenzhen listing channels, the Beijing Stock Exchange has accepted more demand for IPOs, but it is not easy for companies to go public on the Beijing Stock Exchange now. A number of industry insiders pointed out to reporters that on the surface, the number of audits and listings on the Beijing Stock Exchange has clearly accelerated, but due to a greater focus on the properties of novel and innovative drugs, it is actually becoming more difficult for companies to go public.